Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease-Reference-Cited by-同舟云学术

Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease

Published:2013-07-22 Issue:5 Volume:126 Page:591-603
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Goldstein David S.¹,Sullivan Patti¹,Holmes Courtney¹,Miller Gary W.²,Alter Shawn²,Strong Randy³,Mash Deborah C.⁴,Kopin Irwin J.¹,Sharabi Yehonatan¹⁵

Affiliation:

1. Clinical Neurocardiology Section; Clinical Neurosciences Program; Division of Intramural Research; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Bethesda Maryland USA

2. Rollins School of Public Health; Emory University; Atlanta Georgia USA

3. Department of Pharmacology; University of Texas Health Science Center and South Texas Veterans Health Care Network; San Antonio Texas USA

4. Miller School of Medicine; University of Miami; Miami Florida USA

5. Sackler Faculty of Medicine; Tel Aviv University; Tel-HaShomer Israel

Funder

National Institute of Neurological Disorders and Stroke

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jnc.12345/fullpdf

Reference52 articles.

1. Oxidation of 3,4-dihydroxyphenylacetaldehyde, a toxic dopaminergic metabolite, to a semiquinone radical and an ortho-quinone;Anderson;J. Biol. Chem.,2011

2. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease;Bohnen;J. Cereb. Blood Flow Metab.,2006

3. Kinetics and crystal structure of catechol-o-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application;Bonifacio;Mol. Pharmacol.,2002

4. 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis;Burke;Brain Res.,2003

5. Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases;Burke;Neurotoxicology,2004

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinoic acid in Parkinson's disease: Molecular insights, therapeutic advances, and future prospects;Life Sciences;2024-10

2. Ferroptosis—A Shared Mechanism for Parkinson’s Disease and Type 2 Diabetes;International Journal of Molecular Sciences;2024-08-14

3. Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology;NeuroToxicology;2024-07

4. Neurotoxicology of dopamine: Victim or assailant?;NeuroToxicology;2024-07

5. Rethinking Parkinson's disease: could dopamine reduction therapy have clinical utility?;Journal of Neurology;2024-06-21